Years of successfully serving Third-Party Pharmaceutical Manufacturer in India/3rd Party Manufacturing Pharmaceuticals in India Amster Labs leads the way to more stable, happier lives. The faith in the effectiveness, protection, and consistency of the formulations has brought us to the apex of success and built a brand's niche. As a multitude of companies turn to contract manufacturing their current brands and even outsource the production of new products right up to full-scale commercial manufacturing, our reach has broadened further.
Over the years we have been working intensively to master the art of research & innovation-oriented approach in designing formulations for our esteemed clients. Capsules & Capsules, Serum Injections, Dry Powder Injections, Oral Liquids, Ointments & Cream, Dry Syrup, Ophthalmics, We deliver extensive product portfolios of pharmaceutical formulations and Third-Party Pharmaceutical Manufacturer in India covering all major segments; In fact, in all Dosage Types, we are a one-stop solution for pharmaceutical formulations covering nearly all therapeutic segments.
In our tireless efforts to enhance the well-being of people and societies across the globe, we have built various indigenous umbrella innovations to increase the effectiveness, usability, and mitigate the side effects of the product.
Amster Labs always at the service for humanity & health! We continue to boost the momentum of our business, and through partnerships and alliances, we are also accelerating our drug discovery programme. We are determined to focus on new opportunities based on our strong foundations of creativity and entrepreneurship, in order to achieve success in Third-Party Pharmaceutical Manufacturing. As we aggressively execute our growth strategy by organic and inorganic means, we remain committed to strengthening our values. Today, we are among the top 10 manufacturing firms for contracts; we are well positioned to realise our ambitions to be among the top manufacturing firms for contracts and to reach a size of 1500 crores.As we move into the next stage by 2015, we are guided by our optimism, ready to invest in the development of our people and business, marching towards the new horizon of world leadership in pharmaceuticals.